Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 18, 2022

SELL
$32.4 - $68.18 $13,089 - $27,544
-404 Reduced 0.51%
78,720 $5.36 Million
Q2 2022

Aug 15, 2022

BUY
$22.3 - $37.39 $62,306 - $104,467
2,794 Added 3.66%
79,124 $2.53 Million
Q1 2022

May 16, 2022

SELL
$25.68 - $35.59 $125,523 - $173,963
-4,888 Reduced 6.02%
76,330 $2.64 Million
Q4 2021

Feb 15, 2022

BUY
$24.9 - $40.26 $72,832 - $117,760
2,925 Added 3.74%
81,218 $2.38 Million
Q3 2021

Nov 15, 2021

SELL
$25.48 - $37.34 $241,346 - $353,684
-9,472 Reduced 10.79%
78,293 $2 Million
Q2 2021

Aug 16, 2021

SELL
$32.46 - $43.42 $771,736 - $1.03 Million
-23,775 Reduced 21.32%
87,765 $3.07 Million
Q1 2021

May 18, 2021

SELL
$38.94 - $50.85 $21,884 - $28,577
-562 Reduced 0.5%
111,540 $4.55 Million
Q4 2020

Feb 16, 2021

BUY
$37.65 - $63.77 $137,911 - $233,589
3,663 Added 3.38%
112,102 $4.86 Million
Q3 2020

Nov 17, 2020

BUY
$52.76 - $74.49 $404,985 - $571,785
7,676 Added 7.62%
108,439 $5.98 Million
Q2 2020

Aug 17, 2020

BUY
$48.73 - $81.82 $619,699 - $1.04 Million
12,717 Added 14.44%
100,763 $6.36 Million
Q1 2020

May 13, 2020

SELL
$41.72 - $87.2 $18,189 - $38,019
-436 Reduced 0.49%
88,046 $4.5 Million
Q4 2019

Feb 14, 2020

SELL
$45.7 - $81.86 $81,665 - $146,283
-1,787 Reduced 1.98%
88,482 $7.03 Million
Q3 2019

Nov 15, 2019

BUY
$45.35 - $57.91 $292,326 - $373,287
6,446 Added 7.69%
90,269 $4.38 Million
Q2 2019

Aug 14, 2019

BUY
$52.6 - $63.29 $97,310 - $117,086
1,850 Added 2.26%
83,823 $4.41 Million
Q1 2019

May 09, 2019

BUY
$39.99 - $53.48 $148,442 - $198,517
3,712 Added 4.74%
81,973 $4.34 Million
Q4 2018

Feb 13, 2019

BUY
$31.54 - $46.67 $57,371 - $84,892
1,819 Added 2.38%
78,261 $3.21 Million
Q3 2018

Nov 14, 2018

SELL
$38.0 - $51.1 $1,064 - $1,430
-28 Reduced 0.04%
76,442 $2.91 Million
Q2 2018

Aug 14, 2018

BUY
$38.7 - $50.15 $663,937 - $860,373
17,156 Added 28.92%
76,470 $3.46 Million
Q1 2018

May 15, 2018

BUY
$39.6 - $65.9 $44,154 - $73,478
1,115 Added 1.92%
59,314 $2.87 Million
Q4 2017

Feb 14, 2018

SELL
$29.7 - $45.7 $25,512 - $39,256
-859 Reduced 1.45%
58,199 $2.29 Million
Q3 2017

Nov 13, 2017

BUY
$25.1 - $31.05 $1.48 Million - $1.83 Million
59,058
59,058 $1.83 Million

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.